Cambridge Financial Group (Arizona)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
682
-24
-3% -$8.22K 0.08% 141
2026
Q1
$248K Buy
+706
New +$252K 0.08% 152

Other funds holding AMGN

Cambridge Financial Group (Arizona)'s AMGN Position: Q2 2026 in Review

Cambridge Financial Group (Arizona) reduced its Amgen (AMGN) stake by 3.4% in Q2 2026, selling an estimated $8.22K and leaving 682 shares worth $247K. The position accounts for 0.08% of the portfolio, ranked #141.

Cambridge Financial Group (Arizona) first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $248K in Q1 2026. 1,059 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cambridge Financial Group (Arizona) held 682 shares of Amgen worth $247K as of Q2 2026.
  • Cambridge Financial Group (Arizona) sold 24 Amgen shares in Q2 2026, an estimated $8.22K.
  • Amgen made up 0.08% of Cambridge Financial Group (Arizona)'s portfolio in Q2 2026, its #141 holding.
  • Cambridge Financial Group (Arizona) first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • Cambridge Financial Group (Arizona)'s Amgen position peaked at $248K in Q1 2026.
  • 1,059 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cambridge Financial Group (Arizona)'s 13F filing for Q2 2026, filed 14 Jul 2026.